Embryonal rhabdomyosarcomas of the head and neck are rare. Their occurrence in adults is particularly unusual. Moore and Grossi1 reviewed 37 cases, the oldest patient being only 12 years of age. The prognosis is very poor and rapid recurrence is the usual course following either radiation or surgery. Although they are generally considered to be radioresistant, Moore and Grossi found many of them to be radiosensitive. This case is reported because the patient is an adult, age 46, and because of the good response to surgical treatment. Report of Case A 46-year-old housewife was seen first in May, 1958, because of swelling of the right side of her nose for two months. Epiphora had been present on the right for five months. For one month a white mass had been visible in the right nasal vestibule and one week before admission she had brief but brisk epistaxis from the
Archives of Otolaryngolog – American Medical Association
Published: Oct 1, 1960
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera